Proscia wants to bridge technology gap in cancer research
In addition to its cloud-based products for digital pathology, Proscia has released nine image analysis modules targeting prostate, breast, and skin cancer for research use only.
In addition to its cloud-based products for digital pathology, Proscia has released nine image analysis modules targeting prostate, breast, and skin cancer for research use only.
The digital pathology industry cannot advance unless healthcare organizations develop scalable, secure, and accessible IT infrastructures to support it.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Plus, an analysis of the Providence St Joseph Health merger and what the plans are for technology, patient safety and mental health and a look at some of the largest digital health investments outside the U.S.
“Our immediate goal is to improve our software platform and expand our place in the pre-clinical drug discovery market,” noted COO and co-founder Megan Klimen.